Jupiter Neurosciences, Inc.
JUNS
$5.24
-$0.76-12.67%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 40.50K | 21.80K | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 40.50K | 21.80K | -- | -- | -- |
| Cost of Revenue | 2.04M | 2.09M | 2.24M | 1.52M | 860.70K |
| Gross Profit | -2.00M | -2.07M | -2.24M | -1.52M | -860.70K |
| SG&A Expenses | 7.33M | 6.84M | 5.31M | 4.24M | 3.19M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.37M | 8.93M | 7.56M | 5.75M | 4.05M |
| Operating Income | -9.33M | -8.91M | -7.56M | -5.75M | -4.05M |
| Income Before Tax | -9.18M | -8.64M | -7.60M | -5.90M | -3.33M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.18 | -8.64 | -7.60 | -5.90 | -3.33 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.18M | -8.64M | -7.60M | -5.90M | -3.33M |
| EBIT | -9.33M | -8.91M | -7.56M | -5.75M | -4.05M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.26 | -0.25 | -0.23 | -0.18 | -0.10 |
| Normalized Basic EPS | -0.17 | -0.16 | -0.14 | -0.11 | -0.08 |
| EPS Diluted | -0.26 | -0.25 | -0.23 | -0.18 | -0.10 |
| Normalized Diluted EPS | -0.17 | -0.16 | -0.14 | -0.11 | -0.08 |
| Average Basic Shares Outstanding | 140.66M | 138.50M | 131.97M | 128.99M | 123.35M |
| Average Diluted Shares Outstanding | 140.66M | 138.50M | 131.97M | 128.99M | 126.40M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |